Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease
Authors:
- Simon Ulvenes KvernengSKSimon Ulvenes Kverneng
- Kjersti Eline StigeKSKjersti Eline Stige
- Haakon BervenHBHaakon Berven
- Sepideh MostafaviSMSepideh Mostafavi
- Katarina LundervoldKLKatarina Lundervold
- Michele BrischigliaroMBMichele Brischigliaro
- Brage BrakedalBBBrage Brakedal
- Geir Olve SkeieGSGeir Olve Skeie
- Irene Hana FlønesIFIrene Hana Flønes
- Lilah TokerLTLilah Toker
- Erika Fernandez-VizarraEFErika Fernandez-Vizarra
- Ragnhild Eide SkogsethRSRagnhild Eide Skogseth
Preprint
Abstract
Widespread neuronal complex I (CI) deficiency was recently reported to be a characteristic in a subgroup of individuals with idiopathic Parkinson’s disease (PD). Here, we sought to determine whether a CI deficient subgroup could be discerned using clinically accessible muscle biopsy. Vastus lateralis needle biopsies were collected from 83 individuals with PD and 29 neurologically healthy controls and analyzed by immunohistochemistry for complexes I and IV, cytochrome c oxidase/succinate dehydrogenase (COX/SDH) histochemistry, and spectrophotometric activity assays of complexes I-IV. Mitochondrial DNA (mtDNA) copy number, deletions, and point variation were analyzed in single muscle fibers and bulk biopsy samples. PD muscle exhibited reduced CI activity at the group level, with 9% of cases falling below two standard deviations of the control group. This deficiency was not associated with mtDNA abnormalities. Our findings support the existence of a PD subpopulation characterized by CI pathology and suggest that stratification by extra-neural mitochondrial dysfunction may be informative for selecting individuals for clinical trials.Keywords
All Related Versions
- Published version: Communications Medicine, 5 (1), 1.
This publication has 63 references indexed in Scilit:
- Gender Differences in the Prevalence of Parkinson's DiseaseMovement Disorders Clinical Practice, 2022
- The burden of neurological disease in theUnitedStates: A summary report and call to actionAnnals of Neurology, 2017
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scaleMovement Disorders, 2013
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutationsMovement Disorders, 2003
- Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's diseaseAnnals of Neurology, 1998
- Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's diseaseAnnals of Neurology, 1995
- Platelet mitochondria function in Parkinson's diseaseAnnals of Neurology, 1992
- Mitochondrial oxidative phosphorylation defects in parkinson's diseaseAnnals of Neurology, 1991